Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 3Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Visceral Pain 1Neoplasms 1Flushing 1Esophageal Neoplasms 1Cardiovascular Diseases 1Cancer Pain 1Alzheimer Disease 1Agnosia 1Abdominal Pain 1

Interventions

Exercise 8Standard of Care 5trametinib 3tislelizumab 3Radiotherapy 3Radiosurgery 3Palliative Care 3Paclitaxel 3Gemcitabine 3130-nm albumin-bound paclitaxel 3trastuzumab deruxtecan 2cemiplimab 2Therapeutics 2Surveys and Questionnaires 2Resistance Training 2Oxaliplatin 2Nivolumab 2Maintenance 2Immune Checkpoint Inhibitors 2Drug Therapy 2Cisplatin 2Carboplatin 2vedolizumab 1toripalimab 1surufatinib 1sparsentan 1sintilimab 1semaglutide 1posaconazole 1pomalidomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Neoplasms × Ethanol × Clear all
NCT06978673 2025-06-03

CONCERN

Instituto do Cancer do Estado de São Paulo

Phase NA Not yet recruiting
64 enrolled

Cancer Pain, Agnosia, Neoplasms, Abdominal Pain, Visceral Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡